Stay updated on Entrectinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedAdded Revision: v3.3.4; Removed Revision: v3.3.3. No user-facing content or functionality changes observed.SummaryDifference0.0%

- Check7 days agoChange DetectedLocation data updated to add Hubei as a region and update site entries for Guangzhou (528400) and Wuhan (430023) with more complete address details. Old entries such as Guangzhou 510000 and Wuhan 430023 were removed.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's Locations section was updated with a broad list of study sites across the United States and international locations, expanding enrollment options. It also shows removals of several prior site blocks, indicating a reorganization of site listings.SummaryDifference1%

- Check36 days agoChange DetectedThe page now displays 'Last Update Posted (Estimated)' instead of 'Last Update Posted', a minor labeling change to the timestamp field. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedThe study location list has been updated to 130 sites, with new centers in Sichuan, Charlotte, Tampa, and Singapore, among others. Several locations were removed, including Antwerp University Hospital, Sichuan Provincial Cancer Hospital, TU Dresden, Gdańsk, and the National Cancer Centre.SummaryDifference0.7%

- Check50 days agoChange DetectedSite revision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.